The Valley Desk

NCT03491150 · Interventional trial

An Open-Label Crenezumab Study in Participants With Alzheimer's Disease

Overall registry status Terminated

Phase 3

Conditions Alzheimer's Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov